Treatment of Opioid Dependency / Addiction by Subutex (Buprenorphine) Shown Greater Extent Than Clonidine (Catapres)

Treatment of Opioid Dependency / Addiction by Subutex (Buprenorphine) Shown Grea

Physical dependence on a substance is defined by the appearance of characteristic withdrawal symptoms when the substance or behavior is suddenly discontinued. While opioids, benzodiazepines, barbiturates, alcohol and nicotine are all well known for their ability to induce physical dependence.So, while physical dependency can be a major factor in the psychology of addiction and most often becomes a primary motivator in the continuation of an addiction, the primary attribute of an addictive substance is usually its ability to induce pleasure and its facility in becoming routinely used. The user is likely fulfilling his/her physical addiction and, therefore, is achieving pleasurable feelings relative to his/her previous state of physical withdrawal.

You have a problem if you keep craving and using opioids even if it's causing trouble for you. The trouble may be with your health, with money, with work or school, or with your relationships with family or friends. Your friends and family may be aware you're having a problem before you realize it, because they see changes in your behavior. Opioid drugs include :opium ,codeine ,fentanyl ,heroin ,hydrocodone ,methadone ,morphine ,oxycodone,paregoric ,sufentanil .

Breaking a drug addiction is difficult, but not impossible. Support from your doctor, family, friends and others who have a drug addiction, as well as inpatient or outpatient drug addiction treatment, may help you beat your drug dependence.Medicine recommends treatment for people with opioid dependency based on patient placement criteria which attempt to match levels of care according to clinical assessments in six areas, including:

Adolescents addicted to opioids responded better to buprenorphine than clonidine in a clinical trial in which all patients also received behavioral therapy. In the NIDA-supported comparison trial at the University of Vermont, adolescents who received buprenorphine attended more scheduled counseling sessions than peers who received clonidine and had higher rates of successful induction to a relapse prevention regimen of naltrexone.

Naltrexone is a medication that blocks the effects of drugs known as opioids (a class that includes morphine, heroin or codeine). It competes with these drugs for opioid receptors in the brain. It was originally used to treat dependence on opioid drugs but has recently been approved by the FDA as treatment for alcoholism. In clinical trials evaluating the effectiveness of naltrexone, patients who received naltrexone were twice as successful in remaining abstinent and in avoiding relapse as patients who received placebo-an inactive pill. The study, led by Dr. Lisa Marsch, is the first published randomized controlled study of treatments for adolescents addicted to opioids.

"Heroin abuse among American teens has doubled over the past decade, and abuse of prescription opioids such as OxyContin and Vicodin has increased even more," says Dr. Marsch. "In light of those figures, it's important to have a scientific basis for selecting treatments for opioid-dependent teens. We know from previous research and clinical experience that buprenorphine and, to a lesser extent, clonidine are among the medications that have been shown to be effective for treating opioid-addicted adults, but we haven't known how helpful they can be for adolescents."

BUPRENORPHINE DETOXIFICATION SETS STAGE FOR RECOVERY : Opioid-addicted adolescents who entered a detoxification program with buprenorphine were more likely than others receiving clonidine to maintain abstinence throughout a 28-day detoxification program and more likely to begin treatment with naltrexone after detoxification.

Dr. Marsch and colleagues enrolled 36 opioid-addicted adolescents, aged 13 to 18, in a 28-day outpatient treatment program. Half the participants (9 male, 9 female) received buprenorphine in tablet form, the rest (5 male, 13 female) clonidine via transdermal patch; each patient also was given a placebo resembling the other treatment. Medication dosages varied depending on each participant's weight and the amount of drug he or she reported abusing before beginning treatment; dosages of buprenorphine were in the low to moderate range of those typically given to opioid-addicted adults.

All participants also received behavioral therapy based on the Community Reinforcement Approach: three 1-hour sessions each week of counseling on methods to minimize involvement in situations that might lead to drug-taking, training to help recognize and control urges to abuse opioids, and encouragement to recruit family members as allies for abstinence. Participants earned vouchers worth $2.50 for the first opioid-negative urine sample, plus an additional $1.25 for each subsequent one, and a $10 bonus for each set of three consecutive negative samples. Continuous abstinence could earn participants $152.50 in vouchers redeemable for rewards such as ski passes, CDs, gym passes, and clothing.

Buprenorphine and clonidine both supported high rates of abstinence. Among participants who completed treatment, rates were 78 percent and 81 percent, respectively, confirmed by urine samples provided at the thrice-weekly sessions. However, nearly twice as many buprenorphine as clonidine recipients completed the 4-week treatment (72 percent compared with 39 percent). "The high rate of retention in the buprenorphine group is particularly noteworthy," Dr. Marsch says, "because long-term success in recovery is directly related to the amount of time patients spend in treatment." And, she adds, the willingness of most patients who received buprenorphine to continue treatment with naltrexone following completion of the 28-day program is similarly encouraging. Sixty-one percent of the buprenorphine group, but only 5 percent of those who received clonidine accepted naltrexone.

"Dr. Marsch's research is an important first step in systematically studying adolescents who are addicted to opioids," says Dr. Ivan Montoya of NIDA's Division of Pharmacotherapies and Medical Consequences of Drug Abuse. "We know that there are differences in the patterns of opiate abuse and addiction in young people compared with adults. We need dedicated studies like this one to understand how teens are affected by opiate drugs and how best to treat them."

The next step in Dr. Marsch's research will involve a larger sample of young opioid abusers. "We want to evaluate buprenorphine's effectiveness if treatment is extended to 2 months rather than 28 days," she says. "We will also examine the most effective doses and dosing regimens for various subgroups of young patients."


Post new comment


Male Fertility (Sperm Counts) May be Reduced by Hot Bath

Male Fertility (Sperm Counts) May be Reduced by Hot Bath The average chance to conceive for a normally fertile couple having regular, unprotected intercourse is approximately 25 percent during each menstrual cycle. In most couples, conception occurs within

Effective Combination Treatment for Depression with Anger, Irritability, Aggressiveness or Hostility; New Study Shown

Effective Combination Treatment for Depression with Anger, Irritability, Aggress Some people believe that depression is "normal" in people who are elderly, have other health problems, have setbacks or other tragedies, or have bad life situations.Clinical depression affects about

Sleep Deprivation Lowers a Persons Morality

Sleep Deprivation Lowers a Persons Morality Sleep is more important than you may think. Maybe you can think of a time when you didn't get enough sleep. That heavy, groggy feeling is awful and, when you feel that way, you're not at your best.

Recombinant Drug (Cethrin): Might be Effective Treatment for Spinal Cord Injury (SCI) or Myelopathy

Recombinant Drug (Cethrin): Might be Effective Treatment for Spinal Cord Injury Both the brain and the spinal cord are protected by bone: the brain by the bones of the skull, and the spinal cord by a set of ring-shaped bones called vertebrae. They're both cushioned by layers of

Drugs for Schizophrenia May Decrease Sexual Hormone Production in Both Man and Woman

Drugs for Schizophrenia May Decrease Sexual Hormone Production in both Man and W Schizophrenia is a most interesting and vexing disease. Its prevalence is high (0.85 percent), its economic impact is severe, and the disease processes undermine a myriad of brain functions, causing

Moderate to Vigorous Physical Activity May Decrease the Progression of Parkinson’s Disease (PD)

Moderate to Vigorous Physical Activity May Decrease the Progression of Parkinson A major symptom of Parkinson's disease is tremors. A tremor is a rhythmic shaking over which you have no control. Tremors of the hands and sometimes the head often occur along with a constant rubbing

Different Types of Psychiatric Disorders

Different Types of Psychiatric Disorders Classification of Psychiatric Disorders: 1. 'Major' disorders (Psychosis): a) Organic: i) Acute (Delirium) ii) Chronic (Dementia) b) Functional: i) Major depressive illness ii) Schizophrenia. 2. ’